The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs).
D. W. Cescon
No relevant relationships to disclose
M. Ennis
No relevant relationships to disclose
P. A. Ganz
No relevant relationships to disclose
S. Beddows
No relevant relationships to disclose
F. Z. Stanczyk
No relevant relationships to disclose
S. S. Sridhar
No relevant relationships to disclose
P. J. Goodwin
Research Funding - Novartis